期刊文献+

外用“一扫光”药膏致婴儿铅中毒 被引量:4

Lead poisoning caused by externally applied Yisaoguang ointment in an infant
原文传递
导出
摘要 1例5月龄女婴因患湿疹外敷"一扫光"药膏[含红丹(Pb3O4)、铅粉及其他矿物类中药]。治疗10d后,出现精神萎靡、烦躁、轻度贫血等症状。实验室检查显示:ALT 61 U/L,AST 81 U/L,血铅342.3μg/L。疑为急性铅中毒。停用"一扫光"药膏,给予二巯丁二酸及对症治疗,症状好转。之后,给予甲硫氨酸治疗。半月后,血铅及其他实验室指标均恢复正常。 A 5-month-old female infant with eczema was externally applied with Yisaoguang ointment which contains red lead (Pb3O4), ceruse and some other traditional Chinese mineral medicines. Ten days later, she developed listlessness, dysphoria, and mild anaemia. Laboratory tests revealed that her ALT, AST, and lead level were 61 U/L, 81 U/L, and 342.3 μg,/L, respectively. Acute lead poisoning was suspected. Yisaoguang ointment was discontinued. After dimercaptosuceinate and symptomatic treatment, her symptoms were relieved. Subsequently, she was given methionine. Half a month later, her lead level and other laboratory values returned to normal range.
作者 吴娜 王涤新
出处 《药物不良反应杂志》 2008年第5期355-356,共2页 Adverse Drug Reactions Journal
关键词 矿物类中药 “一扫光”药膏 红丹 铅中毒 婴儿 不良反应 traditional Chinese mineral medicine Yisaoguang ointment red lead lead poisoning infant adverse reaction
  • 相关文献

参考文献4

二级参考文献26

  • 1Chavez M. SAMe:S-Adenosylmethionine[J]. Am J Health Sys Pharm, 2000,57: 119-125.
  • 2Mato J M, Albarez L, Ortiz P, et al. S-adenosyl-L-methionine synthetase and methionine metabolism deficiencies in cirrhosis[J].Adv Exp Med, 1994,368:113-119.
  • 3Osman E, Owen J S, Burroughs A K. Review article: Sadenosyl-L-methionine-a new therapeutic agent in liver disease[J]. Alinent Pharmacol Ther, 1993,7(1):21-23.
  • 4Chawla R K, Bonkovsky H L, Galambos J T. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease[J]. Drugs, 1990, 40 (suppl 3):98-110.
  • 5Almasio P, Bortolini M, Pagliaro L, et al. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis [J]. Drugs, 1990,40(suppl 3): 111-119.
  • 6Bressa G M. S-adenosyl-L-methionine(SAMe) as antidepressant: meta-analysis of clinical studies[J]. Acta Neurol Scand Suppl, 1994,154:7-12.
  • 7Bottiglieri T, Hyland K, Reynolds E H. The clinical potential of ademetio-nine(S-adenosylmethionine) in neurological disorders[J]. Drugs, 1994,48: 137-146.
  • 8Bottiglieri T. Ademetionine (S-adenosylme-thionine) neurologicology: Implication for drug therapies in psychiatric and neurological disorders[J]. Expert Opin Invest Drugs, 1997,6(4):417-430.
  • 9Berger R, Nowak H. A new medical approach to the treatment of osteoarthritis. Report of an open Phase Ⅳ study with ademetionine (Gumbaral)[J]. Am J Med, 1987,83(suppl 5A): 84-90.
  • 10Konig B. A long-term (two years) clinical trail with Sadenosylmethionine for the treatment of osteoarthritis[J].Am J Med, 1987,83(suppl 5A) :89-96.

共引文献31

同被引文献136

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部